Results 241 to 250 of about 129,510 (314)

Treatment outcomes and determinants of combined hemodialysis-hemoperfusion therapy in chronic glomerulonephritis. [PDF]

Am J Transl Res
Yuan X, Zhang C.
europepmc   +1 more source

Protective Effect of T-686, an Inhibitor of Plasminogen Activator Inhibitor-1 Production, Against the Lethal Effect of Lipopolysaccharide in Mice

, 1997
Jun Murakami, Akio Ohtani, Sakae Murata
openalex   +1 more source

<i>Yersinia pestis</i> plasminogen activator protease is regulated by the PhoP/PhoQ two-component system. [PDF]

J Bacteriol
Appell KT, Guo W, Scott M, Blevins JS, Pechous RD.   +4 more
europepmc   +1 more source

Synthesis of 1,4-Diphenylbutadiene Derivatives: Novel Inducer of Tissue-Type Plasminogen Activator (t-PA) in Cultured Bovine Endothelial Cells

, 2006
Hiroshi Sai, Tsuyoshi Ogiku, Hiroshi Ohmizu, Akio Ohtani   +3 more
openalex   +2 more sources

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Exploring the genetic frontier: Unraveling ANRIL, PAI-1, and HNF1α in stroke progression. [PDF]

PLoS One
Hamadi A, Mir R, Al-Amer OM, Alasseiri M, Dobie G, Elfaki I, AlZamzami W, Alatawi S, Oyouni AAA, Alanazi MA, Muthupandian S.   +10 more
europepmc   +1 more source

Correlation between soluble urokinase plasminogen activator receptor with CD4 T lymphocyte and WHO clinical staging of HIV infection

, 2010
Shinta Oktya Wardhani, Niniek Budiarti Burhan, Gatoet Ismanoe, Tri Yudani   +3 more
openalex   +2 more sources

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

Acta Ophthalmologica, Volume 104, Issue 1, Page e39-e47, February 2026.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho, Minah Park, Dae Joong Ma, In Hwan Hong, Hyunkyu Kim, Seung Hoon Kim   +5 more
wiley   +1 more source

Novel compound heterozygous mutations in plasminogen (p.Gly568Arg/p.Ala620Thr) impair protein structure and function in type II deficiency: mechanistic insights into a hereditary thrombogenic disorder. [PDF]

Orphanet J Rare Dis
Lu Y, Wang F, Yu D, Xie H, Jin Y, Wang M, Yang L.   +6 more
europepmc   +1 more source